PPAR-γ has been implicated in numerous diseases including obesity, diabetes, atherosclerosis, so that PPAR-γ agonists have been used in the treatment of hyperlipidemia and hyperglycemia [37], and cancer. Here, PPARG is linked to hyperlipidemia.